News
Novo Nordisk experiences heightened competition from copycat versions of its Wegovy obesity drug, affecting its market share, ...
Reuters on MSN1h
Wegovy maker Novo Nordisk to cut costs as competition growsNovo Nordisk is to cut costs as the Wegovy-maker battles competition from rival Eli Lilly and copycat versions of its obesity ...
President Trump’s latest tariff threat has targeted a sector that’s already hobbled.
The outgoing chief executive of Novo Nordisk has revealed plans to ramp-up cost cutting 'efficiencies' across the business, ...
1h
Barchart on MSNIs Wall Street Bullish or Bearish on Eli Lilly Stock?Eli Lilly and Company (LLY), headquartered in Indianapolis, Indiana, is a major American pharmaceutical company. Established ...
BRANCHBURG – Eli Lilly, a multinational pharmaceutical company headquartered in Indianapolis with $45 billion in annual sales, has confirmed that it is selling its facility on Imclone Lane off Route ...
These tariffs would drastically undermine the price advantage Indian drug makers currently enjoy in the US, especially in ...
Danish pharmaceutical giant Novo Nordisk posted a sharp rise in second-quarter net profit Wednesday, but rising competition ...
Novo Nordisk is to cut costs as the Wegovy-maker battles competition from rival Eli Lilly and copycat versions of its obesity ...
While a substantial portion of pipeline assets are externally sourced, many Big Pharmas are tapping into incubators and ...
Booming sales of Wegovy powered the company to become Europe's most valuable, but it has lost over $400 billion in market ...
Trump is pushing drug companies to lower their prices, but experts cast doubt on how effective this endeavor will prove.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results